Research Summary
Analyzed using Evidence Intelligence™

Early insulin degludec improves DKA resolution time

Last updated August 18, 2026

Key finding

DKA resolution was significantly faster in the early degludec group by 3.25 h (7.75 h, IQR 6.00–9.00 h vs. 11.00 h, IQR 6.25–15.00; p = 0.039).

Early combination therapy with insulin degludec and intravenous insulin infusion in adults with diabetic ketoacidosis.

Quick read

Study at a glance

The essential study design details in one scan.

EvidenceScore™

Moderate

Study type

RCTs

Follow-up

Extended (5–20+ y)

Risk of bias

Some Concerns

Save research, organize studies, and quickly find important evidence again.

Plain-language summary

What this paper says

A plain-language read of the study’s main message and where it applies.

Study focus

Early combination therapy with insulin degludec and intravenous insulin infusion in adults with diabetic ketoacidosis.

Clinical relevance

This study evaluated Early combination therapy with insulin degludec and intravenous insulin infusion in adults with diabetic ketoacidosis.

Keep in mind

Limitations were not clearly described in the extracted text.

Published in

Journal Reference

Publication details and source links for this paper.

Kitti T, Methus J, Sirinapa T, Chutintorn S. Early Combination Therapy with Insulin Degludec and Intravenous Insulin Infusion in Diabetic Ketoacidosis Management. Diabetes, Obesity & Metabolism. 2025;27(12). doi:10.1111/dom.70101

Evidence network

How this study fits

Understand where this research contributes within the broader evidence network.

Evidence Context

This study contributes evidence to Insulin degludec and Blood glucose, In-hospital mortality, Incidence of hypoglycaemia, and 5 more.

Primary intervention

Insulin degludec

Primary outcomes

  • Blood glucose
  • In-hospital mortality
  • Incidence of hypoglycaemia

Evidence relationships

Intervention and outcome relationships this study adds to the evidence network.

8
Evidence pairs
8
Relationships
2
Evidence topics
contributes_evidence

Editorial context

Why this study matters

See why this paper is useful beyond its individual results.

Evidence network role

This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.

Moderate contributionModerate confidenceNetwork score: 68

2

Related topics

8

Evidence pairs

297

Related studies

High relevance in at least one topic

Why it is useful

  • Contributes to 8 evidence relationships
  • Includes primary outcome data
  • Linked to 2 direct semantic evidence topics

Topic contributions

Evidence topic

Contributes evidence

Evidence topic

Contributes evidence

Add related evidence to your Evidence Tracker

Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.

Primary evidence

Evidence relationship

Insulin Therapies and Fasting Glucose

Related evidence

Evidence relationship

Insulin Therapies and Hypoglycemia

Save evidence

Evidence topic

Glycemic Control

Save evidence

Core evidence

Study findings

The primary outcomes reported in this study.

Blood glucose

Insulin degludec → Blood glucose

Insulin degludec → Blood glucose

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

In-hospital mortality

Insulin degludec → In-hospital mortality

Insulin degludec → In-hospital mortality

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Incidence of hypoglycaemia

Insulin degludec → Incidence of hypoglycaemia

Insulin degludec → Incidence of hypoglycaemia

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Incidence of hypokalaemia

Insulin degludec → Incidence of hypokalaemia

Insulin degludec → Incidence of hypokalaemia

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Incidence of rebound DKA

Insulin degludec → Incidence of rebound DKA

Insulin degludec → Incidence of rebound DKA

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Incidence of rebound hyperglycaemia

Insulin degludec → Incidence of rebound hyperglycaemia

Insulin degludec → Incidence of rebound hyperglycaemia

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Length of hospital stay

Insulin degludec → Length of hospital stay

Insulin degludec → Length of hospital stay

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
50
Neutral
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Time to DKA resolution

Insulin degludec → Time to DKA resolution

Insulin degludec → Time to DKA resolution

Evidence Intelligence™
EvidenceScore™
Emerging
Score 59 · Based on 1 study
ImpactScore™
100
Very Positive
ConsistencyScore™
unclear
Not enough independent studies
Supporting studies: Based on 1 study
Add to Evidence Tracker

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Evidence Library

Build your evidence library

Save research, organize studies, and quickly find important evidence again.

Connected Evidence

Explore related studies, evidence collections, and research questions.

Relationships organized using the Dediabetes Evidence Intelligence™ framework.

This study contributes to evidence on Insulin Therapies and Fasting Glucose, Insulin Therapies and In-hospital mortality.

Related evidence relationships

Explore in Evidence Explorer

This study contributes to the evidence on the following intervention-outcome relationships.

Questions answered by this study

Generated from the study's connected evidence using Evidence Intelligence™.

Does Insulin Therapies improve fasting glucose?

Strong Evidence

Insulin Therapies may improve Fasting Glucose.

ConsistencyScore™: Results are consistent across studies.

Ranked evidence signals

  1. 1

    Blood glucose

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on 8 supporting studies with consistent results and a positive effect signal.

Limitations

  • Population details are unavailable.
8 supporting studiesUpdated: Aug 2026

Does Insulin Therapies affect hypoglycemia?

Strong Evidence

Insulin Therapies may improve Hypoglycemia.

ConsistencyScore™: Results are generally consistent across studies.

Ranked evidence signals

  1. 1

    Incidence of hypoglycaemia

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on 6 supporting studies with generally consistent results and a positive effect signal.

Limitations

  • Population details are unavailable.
6 supporting studiesUpdated: Aug 2026

Does Insulin degludec improve time to dka resolution?

Emerging Evidence

Insulin degludec appears to improve Time to DKA resolution.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    Time to DKA resolution

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Aug 2026

Does Insulin degludec improve in-hospital mortality?

Emerging Evidence

Current evidence does not show a clear benefit of Insulin degludec for In-hospital mortality.

ConsistencyScore™: Consistency cannot yet be determined from the available evidence.

Ranked evidence signals

  1. 1

    In-hospital mortality

    EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study

Why this answer: This answer is based on a single supporting study.

Limitations

  • Only one supporting study is available.
  • Consistency cannot yet be determined.
  • Population details are unavailable.
1 supporting studyUpdated: Aug 2026
Learn how Evidence Intelligence™ works

Next steps

Continue your research

Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.

No ads. No tracking.

Focused on evidence, not advertising.

Secure & private

Your data is always protected.

Always up to date

New studies added every day.